Abstract Two critical periods of maximum exposure to antigens occur in young mammals, immediately after birth and at weaning, as a result of colonization by commensal bacteria and the ingestion of new diets.
Abstract Two critical periods of maximum exposure to antigens occur in young mammals, immediately after birth and at weaning, as a result of colonization by commensal bacteria and the ingestion of new diets. At weaning, active immune responses of antibody production against dietary proteins are known to occur, but simultaneously, oral tolerance is acquired for harmless food proteins. However, regulated mechanisms of the immune system at weaning remain to be elucidated although its immune responses may be somewhat similar to those in adulthood. Considering that tolerogenic antigen-presenting cells (APCs) are likely to be a key factor in the acquisition of oral tolerance, in the present study, we examined the changes of dendritic cells (DCs) in the lamina propria (LP) on exposure to food proteins at weaning. C57BL/6 female mice were weaned at the age of 3 weeks and orally administered 10 mg of ovalbumin (OVA) for ten consecutive days after weaning. The administration led to a decrease in the plasma level of immunoglobulin specific for OVA, suggesting the acquisition of oral tolerance. The uptake of fluorescence-labeled OVA was significantly observed for CD11c
? LPDCs. DCs. Considering that the change of APCs likely appears immediately on the response to antigen intake, we found the statistically significant increase in the frequency of PDCA-1 ? DCs, but not in that of CD103
? DCs, even after two treatments, indicating PDCA-1 ? DCs to be recruited in the LP within 2 days of exposure to food proteins. These results suggest that the behavior of tolerogenic PDCA-1 ? DCs may change at weaning with the removal of the immunoprotective components of maternal milk.
Keywords Antigens Á Dendritic cells Á Food protein Á Lamina propria Á Oral tolerance Á Weaning Abbreviations APC Antigen-presenting cell DC Dendritic cell LP Lamina propria MLN Mesenteric lymph node OVA Ovalbumin PP Peyer's patch pDC Plasmacytoid dendritic cell Treg Regulatory T Introduction Regulated mechanisms sustain the ability of the gut immune system to distinguish harmless food antigens and commensal bacteria from pathogenic microorganisms, resulting in tolerance versus protective immunity, respectively (Weiner 1997; Mowat 2003) . Oral tolerance is a form of peripheral tolerance that evolved to treat external agents that gain access to the body via a natural route as internal components that then become part of self (Faria and Weiner 2005) . Although the mucosal immune system consists of a variety of lymphocytes and accessory cells such as DCs and macrophages dispersed in the gutassociated lymphoid tissues, including villi, Peyer's patches (PPs), lamina propria (LP), and mesenteric lymph nodes (MLNs), recent reports support that the status of antigen-presenting cells (APCs) determine whether an antigen induces tolerance or protective immunity, depending on how the antigen is presented to antigen-specific T cells by APCs (Steinman et al. 2003; Kelsall and Leon 2005; Belkaid and Oldenhove 2008) .
Oral tolerance was enhanced after the expansion of mucosal DC subsets by the intraperitoneal injection of Flt-3 ligand (Maraskovsky et al. 1996; Viney et al. 1998; Gilliet et al. 2002; Chirdo et al. 2005) . Several lines of evidence demonstrated that CD103
? DCs are able to induce the differentiation of regulatory T (Treg) cells via the production of the vitamin A metabolite, retinoic acid, in the presence of TGF-b, which in addition results in the recruitment of T and B cells to intestinal tissues (Johansson-Lindbom et al. 2005; Benson et al. 2007; Coombes et al. 2007; Sun et al. 2007; Coombes and Powrie 2008; Jaensson et al. 2008; del Rio et al. 2010 ). Kaiserlian's group clearly demonstrated that plasmacytoid DCs (pDCs) carrying dietary antigens in liver tissue is responsible for the induction of oral tolerance and immune suppression affecting both CD4
? and CD8 ? T cell responses (Goubier et al. 2008; Dubois et al. 2009 ). Furthermore, intestinal macrophages were found to display an inflammatory anergy (Smythies et al. 2005) and CD11b
? macrophages in the LP tissues induced Treg cell responses (Denning et al. 2007) . Taken together, APCs in mucosal tissues is likely to be a key factor in the acquisition of oral tolerance.
Two critical periods of maximum exposure to novel antigens occur in young animals, immediately after birth and at weaning (Bailey et al. 2005) . In both cases, the antigenic composition of the intestinal contents can shift suddenly and dramatically, as a result of colonization by commensal bacterial species and the ingestion of a new diet containing non-self antigens. Considerable evidence show that the immune system of neonates is relatively undeveloped compared with that of adults (Vega-Lopez et al. 1995) . Consistent with this observation, newborn animals mount poor responses to antigens, and can often be tolerized by doses of antigen that trigger active responses in adults (Adkins et al. 2004) . Moreover, newborn animals are difficult to tolerize orally (Peng et al. 1989) , suggesting that the major functions of the systemic and local mucosal immune systems are defective at birth. At weaning, however, it remains to be elucidated at the molecular level which types of APCs are responsible for processing the information of non-self antigens for oral tolerance.
In the present study, we examined the changes in LPDCs on exposure to dietary protein at weaning, and found PDCA-1 ? DCs to be recruited to LP immediately after exposure to food.
Materials and methods

Mice
Female C57BL/6 mice at 14-18 days of age were purchased from Japan SLC, Inc. Mice were housed in a conventional room at 22°C, under 12-h cycles of light and dark. The suckling mice were reared with foster mothers and weaned at 21 days of age. They were then placed individually in separate cages and fed a diet containing a mixture of amino acids, the composition of which was based on that of bovine casein. All experiments were approved by the Animal Experimentation Committee at Kyoto University and performed according to institutional guidelines.
Oral tolerance model
The mice weaned at 3 weeks of age were divided into two groups. One of the groups received an intragastric administration of 10 mg of OVA per day for ten consecutive days (Fig. 1a) . On days 0, 2, 4, 6 and 10 after weaning, single cell suspensions were prepared from the spleen and LP of each group. Blood was collected on day 45 in the presence of heparin (10 IU/mL) from tail vein of mice and centrifuged at 900 9g at 4°C for 10 min to prepare the plasma samples.
Antibody levels were determined by enzymelinked immunosorbent assay (ELISA). For OVAspecific antibody levels, 96-well plates were coated with 10 lg/mL OVA overnight at 4°C. Plates were washed three times with TBST solution [50 mM Tris, 0.14 M NaCl, 0.05% Tween 20 (pH 8.0)], and blocked with blocking solution [50 mM Tris, 0.14 M NaCl, 1% BSA (pH 8.0)] for 2 h at room temperature. Following wash step five times, plasma samples were serially diluted across the plate with the diluent [50 mM Tris, 0.14 M NaCl, 1% BSA, 0.05% Tween 20 (pH 8.0)], and incubated for 2 h at room temperature. After another wash step, the plates were incubated with optimized dilutions of HRP-conjugated goat anti-mouse IgG-Fc antibody (Bethyl Laboratories, Inc.) for 1 h at room temperature. The plates were washed extensively and developed with TMB peroxidase substrate (Nacalai Tesque, Japan). After the addition of sulfuric acid to stop enzymatic reaction, absorbance was measured at the wavelength of 450 nm using the microplate reader instrument (Bio-Rad).
Cells
Spleen tissue was mashed between two pieces of frosted glass, and red blood cells were hemolyzed with ACK lysing buffer (Lonza Walkersville, Inc.) to obtain single cell suspensions after extensive washing with PBS. To obtain leukocytes from MLNs and PPs, respectively, isolated lymphoid organs were cut finely with scissors and digested at 37°C for 30-40 min with continuous stirring in the presence of 1 mg/mL collagenase type I (Wako Pure Chemical Industries, Ltd.) and 30 lg/mL DNase I (Roche) in RPMI 1640 medium containing 5% FBS. The digests were passed through 40-lm cell strainers and washed twice with an extensive volume of PBS.
Small intestinal tissue was excised from two mice in each experiment. The tissue samples were removed of PPs, and cut longitudinally after the removal of blood vessels and fat tissue. After mucus was removed from inside the tract by tapping on paper towel, tissues were washed with fresh PBS, and a Experimental design. Mice were reared with foster mothers after birth, weaned at 3 weeks old, and fed a diet composed of an amino acid mixture. Mice in the experimental group received by intragastric gavage of 10 mg of OVA per day. Two weeks after the last gavage, mice were intraperitoneally immunized twice with 100 lg of OVA in the presence of a saponin-based adjuvant. Blood samples were collected from the tail of mice 1 week after the second immunization. Flow cytometry An aliquot of 5 9 10 5 cells was incubated at 4°C for 30 min with 0.5 lg of various fluorochrome-conjugated, or biotinylated, antibodies against cell surface markers in the presence of anti-CD16/CD32 antibody (clone 93; eBioscience) to inhibit non-specific binding to the cell surface. After being washed, the cells were incubated at 4°C for 10 min with fluorochromeconjugated streptavidin when secondary staining was needed. Fluorescence was analyzed for living cells gated in the presence of 7-AAD using a FACSCalibur (BD Biosciences), and data were analyzed with FlowJo software (Tomy Digital Biology Co., Ltd). The antibodies used in the present study are as follows: biotinylated anti mouse CD3e (clone 145-2C11; eBioscience), biotinylated anti mouse CD19 (clone 1D3; BD Biosciences), FITC-conjugated or phycoerythrin (PE)-conjugated anti CD11b (clone M1/70; eBioscience), FITC-conjugated anti CD103 (clone 2E7; eBioscience), FITC-conjugated anti PDCA-1 (clone eBio927; eBioscience), FITC-conjugated anti Gr-1 (clone RB6-8C5; BioLegend), FITCconjugated anti mouse I-A/I-E (clone M5/114.15.2; eBioscience), PE-conjugated anti-mouse CD11c (clone HL3; BD Biosciences), and allophycocyaninconjugated anti mouse CD45 (clone 30-F11; BioLegend).
Results
Induction of oral tolerance by repetitive administration of OVA
We checked whether repetitive intragastric administrations of OVA cause oral tolerance in our protocol. Peritoneal immunization markedly raised the level of plasma immunoglobulin (Ig) against OVA in the mice fed the amino acid mixture without any exogenous protein (ABS ave = 0.34 ± 0.08 [n = 5]) (Fig. 1b ). In contrast, the level of plasma Ig significantly decreased in mice administered OVA (ABS ave = 0.09 ± 0.03 [n = 5]), suggesting the induction of oral tolerance.
Uptake of exogenous antigens by LPDCs
We first compared the frequency of APCs among leukocytes in four lymphoid organs, the spleen, PPs, MLNs, and LP. When the surface antigens of CD11b, CD11c, and MHC class II were used as markers of APCs, the proportion of CD11c
? MHCII ? cells and CD11b
? MHCII ? cells found to be approximately 3.6 and 3.1% in spleen, 3.0 and 0.7% in PPs, 3.0 and 1.9% in MLNs, and 9.6 and 10.7% in LP, respectively. These estimates indicate more APCs in the small intestinal LP than in other lymphoid tissues, such as PPs, MLNs and spleen, under steady-state conditions.
Since Rescigno et al. (2001) revealed that antigens are directly sensed and sampled by LPDCs, we next examined which types of APCs in LP tissue can take exogenous antigens using Alexa 647-labeled OVA. Approximately half of leukocytes in the low-density fraction of LP were found to consist of CD11c 
CD11b
-cells (1.09 ± 0.18% [n = 3]), CD11c (Fig. 2) . Since a large population of CD11c low CD11b
? cells are lacking of the expression of MHC class II molecules, we here focused on the classical antigen presentation which is primarily mediated by a MHC class II-dependent mechanism. Considering the cross-presentation mechanism mediated by a MHC class I molecule, however, we cannot exclude the possibility that CD11c low CD11b ? cells also contribute to antigen uptake and presentation due to their large absolute numbers. These results showed ? DCs showed the tendency to increase in LP of mice fed OVA for ten consecutive days, compared to that of the control mice fed without OVA (Fig. 3) . However, we could not observe significant difference in the frequency of PDCA-1 ? DCs in total CD11c ? MHC II ? DCs (32.8 ± 2.8% for the mice fed with OVA [n = 5], 30.0 ± 2.0% for the control mice [n = 5]). Similarly, the frequency of CD103
? DCs in total CD11c ? MHC II ? DCs remained significantly unchanged (54.1 ± 3.1% for the mice fed with OVA [n = 5]), (48.6 ± 2.0% for the control mice [n = 5]). Considering that the recruitment of DCs in the LP tissue should occur rapidly on exposure of antigens, we analyzed the change in the frequency of PDCA-1 ? DCs upon two treatments. Importantly, as we expect, PDCA-1 ? MHC II ? DCs significantly increased in response to oral stimulation with OVA (34.6 ± 1.1% for the mice fed with OVA [n = 5]), (27.7 ± 2.0% for the control mice [n = 5]) (Fig. 4) . In contrast, the frequency of CD103
? MHC II ? DCs remained unchanged (54.6 ± 4.8% for the mice fed with OVA [n = 6]), (52.9 ± 5.1% for the control mice [n = 6] (data not shown)). These results suggest that, in response to exogenous proteins after weaning, the tolerogenic DC subset expressing PDCA-1 is recruited to the LP tissue of the small intestine.
Discussion
Oral tolerance is of physiological importance because it is a suppressive immunological event for the privileged access of various antigens to the mucosal milieu. This immunological event was not impaired in PPs-deficient mice, whereas the removal of the MLNs led to a reduction in the development of oral tolerance (Spahn et al. 2001; Kraus et al. 2005; Jang et al. 2006 ). These observations suggest that the MLNs is a major site for priming tolerance, and LPDCs may play a key role in the development of oral tolerance by sampling the luminal content and transporting antigens to the MLNs (Worbs et al. 2006; Milling et al. 2010) . Orally administered antigens rapidly gain access to mucosal and systemic lymphoid tissues. Previous studies found regulatory cells in the PPs and MLNs within 24 h after a single feeding of antigen and in the spleen after 4-7 days, and that oral tolerance to systemic challenge is well established within 5-7 days Strobel 1995; Marth et al. 1997; Strobel and Mowat 1998) .
Prevention of antigen influx into the liver has been known to abrogate oral tolerance in response to either protein or hapten (Cantor and Dumont 1967; Yang et al. 1994) . Recently, Goubier et al. (2008) demonstrated that oral tolerance is mediated by plasmocytoid DCs in the liver, and the importance of the liver as an inductive site of oral tolerance by showing that anergy or deletion of antigen-reactive T cells was induced very early after antigen feeding, by day 1 in the liver but several days later in the MLNs, in a CD4
? cell-independent manner. It is conceivable that the very early stage of oral tolerance to a protein or hapten is initiated by the antigen's diffusion through the hepatic route rather than by transport into the draining MLNs. Therefore, the increase in the frequency of pDCs can be regarded as feedback from information on the absorbed antigens in LP as an effector site to discriminate them as safe or not. Our finding that the frequency of pDCs in LP increased 2 days after OVA feeding is in line with reports that anergy or deletion of antigen-reactive T cells is detected by day 1 in the liver and only several days later in the MLNs (Strobel and Mowat 1998; Li et al. 2004; Goubier et al. 2008) . Residual antigen-reactive T cells in LP tissues could be induced to undergo anergy or deletion by the interaction with pDCs, or fully susceptible to suppression by activated Treg cells at mucosal sites conditioned by pDCs. Thus, increased pDCs in LP may also play a role in the inactivation or suppression of antigen-reactive T cells Fig. 3 The frequency of plasmacytoid DCs in LP of the small intestine. Mice were fed 10 mg of OVA for ten consecutive days (OVA(?)) or vehicle (OVA(-)). Cells in the lowdensity fraction were prepared from LP tissues of small intestines as described in ''Materials and methods'', and stained with anti-CD11c, anti-MHC class II, and anti-PDCA-1 or anti-CD103 antibodies. Gated CD11c
? cells were analyzed for MHC class II and PDCA-1 or CD103 expression by a flow cytometer Cytotechnology (2012) 64:221-230 227 at mucosal effector sites. However, it remains unsolved whether pDCs can be produced from monocytes in LP or can be distributed from the liver to be recruited, and it should be addressed at the next step whether the increased population of pDCs exhibits regulatory functions. Multiple mechanisms have been proposed to explain oral tolerance. First, some reports supported an active suppressive mechanism in which antigenspecific Treg cells can be generated by low doses of orally administered antigen Hoyne and Thomas 1995; Yoshida et al. 1997) . In this scenario, gut-associated APCs, such as DCs in PPs and LP, sample the antigens in luminal content, and migrate to the draining MLNs (Jang et al. 2006; Worbs et al. 2006; Milling et al. 2010) . APCs process them intracellularly and present antigenic peptides to naïve T cells to generate Treg cells. Antigenic presentation would preferentially induce T cells that secrete IL-10 or TGF-b cytokines, depending on the propensity of mucosal APCs and gut microenvironment. Such typical APCs are the CD103
? DCs in gutassociated mucosal tissues which controls intestinal homeostasis by a mechanism that relies on TGF-b and retinoic acid signaling. Finally, regulatory cells migrate to lymphoid organs, and inhibit the generation of effector cells to suppress disease by a non-specific mechanism, bystander suppression. In contrast, high doses of orally administered antigens would favor anergy and clonal deletion of effector T cells after antigens pass through the gut barrier. These two forms of tolerance seem not to be mutually exclusive, but rather to overlap and suggest the interactions between DCs and T cells to be essential for the development of oral tolerance. Here we used ten feedings of 10 mg of OVA over 10 days, a regimen typical of high-dose feeding, and observed the changes in frequency of PDCA-1 ? DCs rather than CD103
? DCs in LP tissues. For this reason, a high dose of antigen may cause a more apparent change in PDCA-1 ? DCs than CD103 ? DCs. Alternative possibility is that the weaned mice used in the present study were even younger than the mice usually used for immunological experiments. Several lines of evidence indicate that the mucosal immune system of neonates is rather undeveloped compared with that of adults (Peng et al. 1989; Vega-Lopez et al. 1995; Adkins et al. 2004 ). For example, newborn animals mount poor immune responses to antigens, and can often be tolerized by doses of antigen that trigger active responses in adults. Also, they are known to be difficult to tolerize orally. These results support that the immune functions are relatively different at birth or weaning in both systemic and mucosal aspects from those in adulthood.
In conclusion, we examined the changes of DCs in LP on exposure to dietary proteins at weaning and found that the feeding of OVA after weaning at 3 weeks of age led to an increase in the frequency of PDCA-1 ? DCs in LP within 2 days. A feeding regime able to increase pDC numbers in the gastrointestinal tract may be valuable for the prevention of food allergies and the treatment of bowel inflammatory diseases at weaning when the removal of immunoprotective components in maternal milk occurs. Mice were fed 10 mg of OVA twice, delivered intragastrically in the experimental group (OVA(?)). Cells in the low-density fraction were stained as described in Fig. 3 . The percentage of pDCs among CD11c
? MHC II ? cells was plotted for each mouse. Groups were compared with the unpaired Student's t test as well as the Wilcoxon test, and were significantly different in both tests (*p \ 0.05)
